GP100 Intron 4 Peptide (VYFFLPDHL)

GP100 Intron 4 Peptide (VYFFLPDHL)

gp100/pmel, also known as pmel17, is a melanoma-associated differentiation antigen that is investigated as a target in melanoma immunotherapy.
RP30964
¥10,000.00

Ask us a question
Description

gp100/pmel, also known as pmel17, is a melanoma-associated differentiation antigen that is investigated as a target in melanoma immunotherapy.

Overview
Synonyms GP100 Intron 4 Peptide (VYFFLPDHL)
Description gp100/pmel, also known as pmel17, is a melanoma-associated differentiation antigen that is investigated as a target in melanoma immunotherapy.
Sequence
{Val}{Tyr}{Phe}{Phe}{Leu}{Pro}{Asp}{His}{Leu}
Sequence Shortening VYFFLPDHL
Molecular Formula C59H79N11O13
Molecular Weight 1150.35

Properties
Length 9
Purity >95%
Solubility Soluble in dimethyl sulfoxide(Analytical grade) under 1mg/ml
Form Lyophilized
Storage Store at -20°C. Keep tightly closed. Store in a cool dry place.